FRPT reaches a key milestone, marking its 25th consecutive quarter of more than 25% year-on-year net sales growth.
Japanese gynecological benign tumor market is thriving with cutting-edge diagnostic technologies and minimally invasive ...
Petroleo Brasileiro S/A Ord-0.76% R$479.42B Petroleo Brasileiro S/A Pref-0.20% R$479.42B ...
Aptiv PLC $54.41-1.52-2.72% ...